BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33372433)

  • 1. Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data.
    Akıcı N; Kırmızı Nİ; Aydın V; Bayar B; Aksoy M; Akıcı A
    Turk J Pediatr; 2020; 62(6):949-961. PubMed ID: 33372433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of biotechnological drugs in rare diseases requiring the use of off-label drugs in children in Turkey.
    Kırmızı Nİ; Aydın V; Akıcı N; Bayar B; Akıcı A
    Turk J Med Sci; 2021 Aug; 51(4):1791-1799. PubMed ID: 33600094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nationwide evaluation of off-label drug utilization in Turkey.
    Özdamar EN; Akıcı A; Alkan A; Bayar B; Gürsöz H
    Turk J Med Sci; 2017 Aug; 47(4):1229-1238. PubMed ID: 29156868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Pattern Monitoring and Off-label Use of Medicines in the Pediatric Department at Tertiary Care Teaching Hospital.
    Pandey S; Yadav CK; Ghimire P; Shrestha AC
    Kathmandu Univ Med J (KUMJ); 2020 Oct.-Dec.; 18(72):367-371. PubMed ID: 34165093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
    Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
    Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
    Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
    Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label drug prescriptions in French general practice: a cross-sectional study.
    Drogou F; Netboute A; Giai J; Dode X; Darmon D; Kassai B; Letrilliart L
    BMJ Open; 2019 Apr; 9(4):e026076. PubMed ID: 30967407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of clinical trials and off-label drug use in hospitalized pediatric patients.
    Roldán T; Villamañán E; Ruano M; Larrubia Y; Gómez-Salcedo P; Herrero A
    Arch Argent Pediatr; 2014 Jun; 112(3):249-53. PubMed ID: 24862807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches.
    Carnovale C; Conti V; Perrone V; Antoniazzi S; Pozzi M; Merlino L; Venegoni M; Clementi E; Radice S
    Eur J Pediatr; 2013 Dec; 172(12):1679-85. PubMed ID: 23913312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten common questions (and their answers) about off-label drug use.
    Wittich CM; Burkle CM; Lanier WL
    Mayo Clin Proc; 2012 Oct; 87(10):982-90. PubMed ID: 22877654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label prescribing for children with chronic diseases in Nigeria; findings and implications.
    Oshikoya KA; Oreagba IA; Godman B; Fadare J; Orubu S; Massele A; Senbanjo IO
    Expert Opin Drug Saf; 2017 Sep; 16(9):981-988. PubMed ID: 28627939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric off-label use of drugs in Gansu, China: a multicentre cross-sectional study.
    Meng M; Ge B; Lei W; Wu Y; Tian M; Lu Y; Shao T; Yang Y; Luo X; Luo J; Gao Y; Li Q; Chen Y
    BMJ Open; 2024 May; 14(5):e078126. PubMed ID: 38740506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
    Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
    BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for unlicensed and off-label drug use in children outside the hospital.
    Schirm E; Tobi H; de Jong-van den Berg LT
    Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of prescriptions of off-label drugs and drugs not approved for pediatric use in primary health care in a southern municipality of Brazil].
    Gonçalves MG; Heineck I
    Rev Paul Pediatr; 2016; 34(1):11-7. PubMed ID: 26530249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care--a nationwide study.
    Olsson J; Kimland E; Pettersson S; Odlind V
    Acta Paediatr; 2011 Sep; 100(9):1272-5. PubMed ID: 21438922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label prescribing to children in the United States outpatient setting.
    Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
    Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Situation analysis of off-label drug use in China].
    Rui-Xue HU; Mei MO; Dan-Dan YU; Hui-Min LI; Xing L; Xiao-Jiao D; Yu-Bo G
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4277-4284. PubMed ID: 33164415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.